Southeastern Sexually Transmitted Infections Cooperative Research Center
东南部性传播感染合作研究中心
基本信息
- 批准号:8519209
- 负责人:
- 金额:$ 253.64万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1997
- 资助国家:美国
- 起止时间:1997-07-01 至 2015-08-31
- 项目状态:已结题
- 来源:
- 关键词:AdherenceAdjuvantAnimalsDevelopmentFamily suidaeGeneticGonorrheaHemophilus ducreyiHumanImmune responseImmunizationImmunobiologyImmunologic MonitoringImmunologyInfectionIronMediator of activation proteinMembrane ProteinsMicrobiologyModelingMolecularMusNatural ImmunityNeisseria gonorrhoeaePathogenesisPreventionProtocols documentationResearchResistanceSexually Transmitted DiseasesSpecimenVaccinesgonorrhea vaccinemucosal vaccinenovel strategiespathogenpreventresearch studyvaccine candidate
项目摘要
This is a competing renewal for a Sexually Transmitted Infections Cooperative Research Center (STI ORG). The Southeastern STI ORG is comprised of six projects Including studies on the sexually transmitted pathogens Neisseria gonorrhoeae and Haemophilus ducreyi. Five synergistic projects explore molecular pathogenesis, immunobiology and possible vaccines for gonorrhea, and the sixth project focuses on development of a promising vaccine for H. ducreyi. The six projects are supported by an Administrative Core, a Microbiology Core and an Immunology Core. Project 1 uses the murine model of gonococcal infection to study mucosal vaccine candidates. Project 2 focuses on iron-regulated adherence factors of N. gonorrhoeae. Project 3 deals with genetic mechanisms of gonococcal resistance to mediators of innate immunity. Project 4 aims at preventing gonococcal infection by targeting the adherence factor PilG. Project 5 centers on innate host immune responses to gonococcal infection. Project 6 focuses on the H. ducreyi outer membrane protein DsrA as a chancroid vaccine using a swine model of infection. The Microbiology Core will conduct experimental human gonococcal infection experiments in support of Projects 2-5. The Immunology Core provides expertise In mucosal adjuvants and immunization protocols for gonococcal studies in mice and chancroid studies in pigs and sophisticated immune monitoring using specimens from animals and humans. The overall theme uniting these projects and cores is New Approaches to STI Prevention.
这是性传播感染合作研究中心(STI ORG)的竞争性更新。东南STI ORG由六个项目组成,包括对性传播病原体淋病奈瑟菌和杜克雷嗜血杆菌的研究。五个协同项目探索淋病的分子发病机制、免疫生物学和可能的疫苗,第六个项目集中于开发有希望的H. ducreyi。这六个项目由一个行政核心、一个微生物学核心和一个免疫学核心支持。项目1使用淋球菌感染的小鼠模型来研究粘膜疫苗候选物。项目2主要研究铁调节的N.淋病项目3涉及淋球菌对先天免疫介质的抗性的遗传机制。项目4旨在通过靶向粘附因子PilG来预防淋球菌感染。项目5的中心是淋球菌感染的先天宿主免疫反应。项目6的重点是H. ducreyi外膜蛋白DsrA作为软下疳疫苗,使用猪感染模型。微生物学中心将进行人类淋球菌感染实验,以支持项目2-5。免疫学核心为小鼠淋球菌研究和猪软下疳研究提供粘膜佐剂和免疫方案方面的专业知识,并使用动物和人类标本进行复杂的免疫监测。将这些项目和核心项目结合在一起的总主题是预防性传播感染的新方法。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
MARCIA METZGAR HOBBS其他文献
MARCIA METZGAR HOBBS的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('MARCIA METZGAR HOBBS', 18)}}的其他基金
Experimental human infection with isogenic mutants of Neisseria gonorrhoeae
淋病奈瑟菌同基因突变体的实验性人类感染
- 批准号:
9474102 - 财政年份:2015
- 资助金额:
$ 253.64万 - 项目类别:
Experimental human infection with isogenic mutants of Neisseria gonorrhoeae
淋病奈瑟菌同基因突变体的实验性人类感染
- 批准号:
8925976 - 财政年份:2015
- 资助金额:
$ 253.64万 - 项目类别:
Experimental human infection with isogenic mutants of Neisseria gonorrhoeae
淋病奈瑟菌同基因突变体的实验性人类感染
- 批准号:
9267906 - 财政年份:2015
- 资助金额:
$ 253.64万 - 项目类别:
Human Challenge Study of Isogenic Mutants of Neisseria Gonorrhoeae
淋病奈瑟菌同基因突变体的人体挑战研究
- 批准号:
6980564 - 财政年份:2003
- 资助金额:
$ 253.64万 - 项目类别:
HAEMOPHILUS DUCREYI INFECTION OF ARTIFICIAL SKIN
人造皮肤的杜克雷嗜血杆菌感染
- 批准号:
2059583 - 财政年份:1996
- 资助金额:
$ 253.64万 - 项目类别:
相似海外基金
Metachronous synergistic effects of preoperative viral therapy and postoperative adjuvant immunotherapy via long-term antitumor immunity
术前病毒治疗和术后辅助免疫治疗通过长期抗肿瘤免疫产生异时协同效应
- 批准号:
23K08213 - 财政年份:2023
- 资助金额:
$ 253.64万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Improving the therapeutic immunity of cancer vaccine with multi-adjuvant polymeric nanoparticles
多佐剂聚合物纳米粒子提高癌症疫苗的治疗免疫力
- 批准号:
2881726 - 财政年份:2023
- 资助金额:
$ 253.64万 - 项目类别:
Studentship
Countering sympathetic vasoconstriction during skeletal muscle exercise as an adjuvant therapy for DMD
骨骼肌运动期间对抗交感血管收缩作为 DMD 的辅助治疗
- 批准号:
10735090 - 财政年份:2023
- 资助金额:
$ 253.64万 - 项目类别:
Evaluation of the Sensitivity to Endocrine Therapy (SET ER/PR) Assay to predict benefit from extended duration of adjuvant endocrine therapy in the NSABP B-42 trial
NSABP B-42 试验中内分泌治疗敏感性 (SET ER/PR) 测定的评估,用于预测延长辅助内分泌治疗持续时间的益处
- 批准号:
10722146 - 财政年份:2023
- 资助金额:
$ 253.64万 - 项目类别:
AUGMENTING THE QUALITY AND DURATION OF THE IMMUNE RESPONSE WITH A NOVEL TLR2 AGONIST-ALUMINUM COMBINATION ADJUVANT
使用新型 TLR2 激动剂-铝组合佐剂增强免疫反应的质量和持续时间
- 批准号:
10933287 - 财政年份:2023
- 资助金额:
$ 253.64万 - 项目类别:
DEVELOPMENT OF SAS A SYNTHETIC AS01-LIKE ADJUVANT SYSTEM FOR INFLUENZA VACCINES
流感疫苗类 AS01 合成佐剂系统 SAS 的开发
- 批准号:
10935776 - 财政年份:2023
- 资助金额:
$ 253.64万 - 项目类别:
DEVELOPMENT OF SMALL-MOLECULE DUAL ADJUVANT SYSTEM FOR INFLUENZA VIRUS VACCINE
流感病毒疫苗小分子双佐剂体系的研制
- 批准号:
10935796 - 财政年份:2023
- 资助金额:
$ 253.64万 - 项目类别:
A GLYCOLIPID ADJUVANT 7DW8-5 FOR MALARIA VACCINES
用于疟疾疫苗的糖脂佐剂 7DW8-5
- 批准号:
10935775 - 财政年份:2023
- 资助金额:
$ 253.64万 - 项目类别:
Adjuvant strategies for universal and multiseasonal influenza vaccine candidates in the context of pre-existing immunity
在已有免疫力的情况下通用和多季节流感候选疫苗的辅助策略
- 批准号:
10649041 - 财政年份:2023
- 资助金额:
$ 253.64万 - 项目类别:
Adjuvant Photodynamic Therapy to Reduce Bacterial Bioburden in High-Energy Contaminated Open Fractures
辅助光动力疗法可减少高能污染开放性骨折中的细菌生物负载
- 批准号:
10735964 - 财政年份:2023
- 资助金额:
$ 253.64万 - 项目类别:














{{item.name}}会员




